Last edition
News about "Harbour Mice platform "
Nona Biosciences Partners with Medical University of Vienna on Antibody Research
Nona Biosciences has partnered with the Medical University of Vienna to advance fully human antibody development for infectious diseases using its H2L2 Harbour Mice platform.
Harbour Mice Platform | 23/07/2026 | By News Bureau
Harbour BioMed Signs Strategic Collaboration with Lannacheng on Radionuclide Drug Conjugates
Harbour BioMed has entered into a long-term strategic collaboration with Yantai Lannacheng Biotechnology to jointly advance the development of next-generation radionuclide drug conjugates, combining both companies’ resources and expertise to accelerate innovation in targeted radiopharmaceutical therapies.
Harbour Mice Platform | 30/12/2025 | By News Bureau | 169
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy